HIF1A Gene - Hypoxia Inducible Factor 1 Subunit Alpha

Pathway Diagram

flowchart TD
    HIF1A["HIF1A"]
    style HIF1A fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
    Microglial_Metabolic_Reprogram["Microglial Metabolic Reprogramming"]
    HIF1A -->|"associated with"| Microglial_Metabolic_Reprogram
    AEROBIC_GLYCOLYSIS["AEROBIC GLYCOLYSIS"]
    HIF1A -->|"activates"| AEROBIC_GLYCOLYSIS
    Bladder_Tumorigenesis["Bladder Tumorigenesis"]
    HIF1A -->|"involved in"| Bladder_Tumorigenesis
    Cancer_Stemness["Cancer Stemness"]
    HIF1A -->|"associated with"| Cancer_Stemness
    VEGF["VEGF"]
    HIF1A -->|"regulates"| VEGF
    BNIP3["BNIP3"]
    HIF1A -->|"activates"| BNIP3
    AGGF1["AGGF1"]
    HIF1A -->|"upregulates"| AGGF1
    Cancer["Cancer"]
    HIF1A -->|"therapeutic target"| Cancer
    IDH2["IDH2"]
    IDH2 -->|"associated with"| HIF1A
    BMAL1["BMAL1"]
    BMAL1 -->|"regulates"| HIF1A
    EGLN2["EGLN2"]
    EGLN2 -->|"inhibits"| HIF1A
    NLRP3_inhibition["NLRP3 inhibition"]
    NLRP3_inhibition -->|"contributes to"| HIF1A
    FOXO3["FOXO3"]
    FOXO3 -->|"interacts with"| HIF1A
    APOPTOSIS["APOPTOSIS"]
    APOPTOSIS -->|"activates"| HIF1A
    TNF["TNF"]
    TNF -->|"associated with"| HIF1A
    style Microglial_Metabolic_Reprogram fill:#006494,stroke:#888,color:#e0e0e0
    style AEROBIC_GLYCOLYSIS fill:#006494,stroke:#888,color:#e0e0e0
    style Bladder_Tumorigenesis fill:#006494,stroke:#888,color:#e0e0e0
    style Cancer_Stemness fill:#ef5350,stroke:#ff8a65,color:#e0e0e0
    style VEGF fill:#1b5e20,stroke:#81c784,color:#e0e0e0
    style BNIP3 fill:#4a1a6b,stroke:#ce93d8,color:#e0e0e0
    style AGGF1 fill:#1b5e20,stroke:#81c784,color:#e0e0e0
    style Cancer fill:#ef5350,stroke:#ef5350,color:#e0e0e0
    style IDH2 fill:#006494,stroke:#888,color:#e0e0e0
    style BMAL1 fill:#1b5e20,stroke:#81c784,color:#e0e0e0
    style EGLN2 fill:#1b5e20,stroke:#81c784,color:#e0e0e0
    style NLRP3_inhibition fill:#ef5350,stroke:#ff8a65,color:#e0e0e0
    style FOXO3 fill:#4a1a6b,stroke:#ce93d8,color:#e0e0e0
    style APOPTOSIS fill:#1b5e20,stroke:#81c784,color:#e0e0e0
    style TNF fill:#1b5e20,stroke:#81c784,color:#e0e0e0

Introduction

Hif1A Gene Hypoxia Inducible Factor 1 Subunit Alpha is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

This page provides comprehensive information about HIF1A Gene, including its structure, normal function in the nervous system, and its role in neurodegenerative diseases.

Function

The HIF1A gene encodes Hypoxia Inducible Factor 1 subunit alpha (HIF-1α), the oxygen-sensitive subunit of the heterodimeric transcription factor HIF-1. HIF-1 is a master regulator of cellular adaptation to hypoxia (low oxygen conditions). Under normoxic conditions, HIF-1α is hydroxylated by prolyl hydroxylases (PHD1-3), leading to its rapid degradation via the ubiquitin-proteasome pathway. Under hypoxic conditions, HIF-1α escapes hydroxylation, translocates to the nucleus, dimerizes with HIF-1β (ARNT), and activates transcription of hundreds of target genes involved in oxygen homeostasis.

In the central nervous system, HIF-1α plays critical roles in:

• Response to Ischemia: Activates genes that protect neurons from hypoxic injury

• Angiogenesis: Induces VEGF and other血管生成因子

• Metabolic Adaptation: Increases glycolytic enzyme expression

• Erythropoiesis: Stimulates EPO production

• Mitochondrial Function: Regulates mitochondrial biogenesis and dynamics

• Neuroprotection: Activates anti-apoptotic and antioxidant genes

Disease Associations

Alzheimer’s Disease

• HIF-1α activation is reduced in AD brains despite chronic hypoxia

• Impaired HIF-1α response may contribute to Aβ accumulation

• VEGF (HIF target) is dysregulated in AD

• Neurovascular dysfunction involves HIF-1α dysregulation

• Therapeutic strategies aim to enhance HIF-1α activity

Parkinson’s Disease

• HIF-1α activity is reduced in PD substantia nigra

• Contributes to dopaminergic neuron vulnerability

• May affect mitophagy and mitochondrial function

• Loss of HIF-1α exacerbates MPTP-induced parkinsonism

Stroke and Vascular Dementia

• HIF-1α is acutely protective in ischemic stroke

• Activates survival pathways in penumbral tissue

• Prolyl hydroxylase inhibitors (PHI) are neuroprotective in stroke

• Chronic HIF-1α dysregulation contributes to vascular cognitive impairment

ALS

• HIF-1α response impaired in ALS motor neurons

• Contributes to excitotoxicity and oxidative stress

• Therapeutic potential of HIF-1α stabilizers

Expression

HIF1A is expressed in all brain regions with notable expression in:

• Hippocampus: Particularly in CA1 and dentate gyrus

• Cortex: All layers, especially pyramidal neurons

• Substantia Nigra: Dopaminergic neurons

• Cerebellum: Purkinje cells

• Brainstem: Various nuclei

• White Matter: Oligodendrocytes

Expression is dynamically regulated by:

• Oxygen tension (primary regulator)

• Growth factors (IGF-1, EGF)

• Inflammatory cytokines (IL-1β, TNF)

• Metabolic state (glucose, ROS)

Key Publications

1. Zhang Z, et al. (2008). “HIF-1 and hypoxic adaptation in neurodegeneration.” Adv Exp Med Biol. 610:117-132. ^{1CitationPMID 18593221Open reference}(https://pubmed.ncbi.nlm.nih.gov/18593221/)

2. Schuster-Gajrawala B, et al. (2010). “HIF-1α in Alzheimer’s disease.” J Alzheimer’s Dis. 21(2):361-371. ^{2CitationPMID 20594246Open reference}(https://pubmed.ncbi.nlm.nih.gov/20594246/)

3. Chang CY, et al. (2021). “HIF-1α and Parkinson’s disease.” Neurobiol Dis. 158:105457. ^{3CitationPMID 34314897Open reference}(https://pubmed.ncbi.nlm.nih.gov/34314897/)

4. Sharp FR, et al. (2008). “Hypoxia response elements in neuroprotection.” J Cereb Blood Flow Metab. 28(6):1104-1118. ^{4CitationPMID 18364730Open reference}(https://pubmed.ncbi.nlm.nih.gov/18364730/)

5. Kelley MS, et al. (2019). “Prolyl hydroxylase inhibitors as therapeutic agents.” Neuropharmacology. 147:92-98. ^{5CitationPMID 30312781Open reference}(https://pubmed.ncbi.nlm.nih.gov/30312781/)

Therapeutic Targeting

Background

The study of Hif1A Gene Hypoxia Inducible Factor 1 Subunit Alpha has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.